INDV
Indivior Pharmaceuticals, Inc.
35.90$
-0.3%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 42.0% | 25.7% | 31.6% | 19.2% | -29.8% | 44.6% | -0.4% | -27.4% | 3.0% | -2.2% | |
| 1.4% | 1.1% | 1.7% | 3.6% | 4.0% | 2.8% | 1.8% | 1.4% | 2.4% | 1.6% | |
| 1.0% | 1.4% | 1.6% | 0.4% | 1.2% | 1.4% | 1.8% | 1.9% | 2.0% | 2.1% | |
| – | – | – | 8.7% | -8.0% | -5.9% | -10.8% | – | – | – | |
| 34.9% | 12.3% | 3.0% | -10.1% | -2.9% | 21.9% | 13.1% | -27.2% | -3.9% | -20.7% | |
| 3.6% | 3.7% | 4.3% | 0.9% | 0.6% | 4.3% | 0.6% | 4.8% | 2.6% | 5.4% | |
| -3.6% | -3.7% | -0.4% | -0.3% | -0.6% | -1.8% | -24.6% | -8.7% | 5.8% | -5.3% | |
| 7.1% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0% | -12.8% | -10.0% | -3.0% | -14.6% | -0.9% | |
| – | – | – | -1.7% | -1.7% | 0.8% | -1.3% | -1.1% | 7.7% | -1.4% | |
| -15.2% | -7.3% | -24.7% | -1.7% | -1.5% | -11.9% | -11.2% | -5.9% | -8.6% | -2.4% | |
| 23.2% | 14.9% | 6.4% | 17.3% | -31.2% | 30.8% | -36.4% | -41.9% | 0.3% | -10.0% | |
| 38.4% | 21.9% | 27.3% | 18.3% | -30.4% | 40.3% | -1.0% | -32.3% | 0.4% | -7.6% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.